Top news of the week: 11.02.2021.
Healthcare
Merck CEO says public service is in his future, but not politics, as he plans June retirement
Merck CEO Ken Frazier is retiring in June. He leaves a legacy of a focus on research, and a commitment to social justice that he's likely to continue.
Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors
The adeno-associated viruses often used as vectors to deliver gene therapy can trigger unwanted and sometimes dangerous immune responses. Now, a Harvard University team led by renowned ...
China Approves Sinovac Biotech COVID-19 Vaccine
It marks the second vaccine approved for public use in China.
The Promise of Data Science in Biotechnology
While data science is now permeating industries where predictive models and big data can have a massive impact on humanity, it plays a crucial role in biotechnology.
China approves Sinovac Biotech COVID-19 vaccine for general public use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical ...
China approves Sinovac Biotech Covid-19 vaccine for general public use
The CoronaVac vaccine has already been given to key groups deemed to be at higher risk of exposure to the virus.. Read more at straitstimes.com.
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation
Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC. The ...
Company News: Cardior’s pioneering miRNA approach in heart failure endorsed by expert opinions in the European Heart Journal
— First-ever development of an RNA therapeutic for heart failure — Successful translation of unique scientific discovery into first-in-class clinical program Cardior …